HUP0300183A2 - Sejt adhézió inhibítorként ható szubsztituált purinszármazékok - Google Patents

Sejt adhézió inhibítorként ható szubsztituált purinszármazékok

Info

Publication number
HUP0300183A2
HUP0300183A2 HU0300183A HUP0300183A HUP0300183A2 HU P0300183 A2 HUP0300183 A2 HU P0300183A2 HU 0300183 A HU0300183 A HU 0300183A HU P0300183 A HUP0300183 A HU P0300183A HU P0300183 A2 HUP0300183 A2 HU P0300183A2
Authority
HU
Hungary
Prior art keywords
cell adhesion
inhibitors
compounds
purine derivatives
substituted purine
Prior art date
Application number
HU0300183A
Other languages
English (en)
Inventor
Thomas R. Gadek
Jean-Francois Gourvest
Jochen Knolle
Anuschirwan Peyman
Jean-Marie Ruxer
Original Assignee
Aventis Pharma Deutschland Gmbh.
Genentech Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh., Genentech Inc. filed Critical Aventis Pharma Deutschland Gmbh.
Publication of HUP0300183A2 publication Critical patent/HUP0300183A2/hu
Publication of HUP0300183A3 publication Critical patent/HUP0300183A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány (I) általános képletű vegyületekre vonatkozik, ahol aszubsztituensek jelentését az igénypontok tartalmazzák. A vegyületekvitronektin receptor antagonisták, és sejtadhézió inhibitorok. Atalálmány a vegyületek előállítására szolgáló eljárásra, avegyületeket tartalmazó gyógyszerészeti készítményekre és a vegyületekalkalmazására is vonatkozik. Ó
HU0300183A 1999-07-02 2000-06-26 Substituted purine derivatives as inhibitors of cell adhesion HUP0300183A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99112637A EP1065208A1 (en) 1999-07-02 1999-07-02 Substituted purine derivatives as inhibitors of cell adhesion
PCT/EP2000/005921 WO2001002399A1 (en) 1999-07-02 2000-06-26 Substituted purine derivatives as inhibitors of cell adhesion

Publications (2)

Publication Number Publication Date
HUP0300183A2 true HUP0300183A2 (hu) 2003-06-28
HUP0300183A3 HUP0300183A3 (en) 2005-12-28

Family

ID=8238483

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300183A HUP0300183A3 (en) 1999-07-02 2000-06-26 Substituted purine derivatives as inhibitors of cell adhesion

Country Status (30)

Country Link
US (1) US6747016B1 (hu)
EP (2) EP1065208A1 (hu)
JP (1) JP2003503497A (hu)
KR (1) KR20020015997A (hu)
CN (1) CN1171888C (hu)
AR (1) AR034242A1 (hu)
AT (1) ATE262528T1 (hu)
AU (1) AU774382B2 (hu)
BG (1) BG106229A (hu)
BR (1) BR0012050A (hu)
CA (1) CA2376673A1 (hu)
CZ (1) CZ20014553A3 (hu)
DE (1) DE60009296T2 (hu)
EA (1) EA005372B1 (hu)
EE (1) EE200100713A (hu)
ES (1) ES2219353T3 (hu)
HU (1) HUP0300183A3 (hu)
IL (1) IL147245A0 (hu)
MX (1) MXPA01013241A (hu)
MY (1) MY122631A (hu)
NO (1) NO20016403L (hu)
NZ (1) NZ516095A (hu)
PL (1) PL352281A1 (hu)
SK (1) SK18792001A3 (hu)
TR (1) TR200103858T2 (hu)
TW (1) TWI229080B (hu)
UA (1) UA72923C2 (hu)
WO (1) WO2001002399A1 (hu)
YU (1) YU89701A (hu)
ZA (1) ZA200200017B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042655A1 (de) * 2000-08-31 2002-03-14 Aventis Pharma Gmbh Verfahren zur Herstellung von Inhibitoren der Zell-Adhäsion
FR2847254B1 (fr) 2002-11-19 2005-01-28 Aventis Pharma Sa Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant
FR2870541B1 (fr) 2004-05-18 2006-07-14 Proskelia Sas Derives de pyrimidines antigonistes du recepteur de la vitronectine
ES2684821T3 (es) 2005-12-29 2018-10-04 Lexicon Pharmaceuticals, Inc. Derivados de aminoácidos multicíclicos y métodos de su uso
CL2007002994A1 (es) * 2006-10-19 2008-02-08 Wyeth Corp Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
CN107450106A (zh) * 2017-09-28 2017-12-08 北京小米移动软件有限公司 饮水安全提示方法、装置及智能水杯
WO2021226261A1 (en) 2020-05-06 2021-11-11 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
AU2022388555A1 (en) 2021-11-09 2024-05-02 Ajax Therapeutics, Inc. 6-he tero aryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741796A (en) * 1994-05-27 1998-04-21 Merck & Co., Inc. Pyridyl and naphthyridyl compounds for inhibiting osteoclast-mediated bone resorption
EP0934305A4 (en) * 1996-08-29 2001-04-11 Merck & Co Inc INTEGRINE ANTAGONISTS
AU717283B2 (en) * 1996-10-30 2000-03-23 Merck & Co., Inc. Integrin antagonists
DE19653646A1 (de) * 1996-12-20 1998-06-25 Hoechst Ag Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung
AU729869B2 (en) * 1997-01-17 2001-02-15 Merck & Co., Inc. Integrin antagonists
WO1999037621A1 (en) * 1998-01-23 1999-07-29 Aventis Pharma Deutschland Gmbh Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
WO1999038621A1 (en) 1998-01-28 1999-08-05 Danmist Aps Method of piezoelectrically atomising and pumping fluids and piezoelectric fluid atomising and pumping device

Also Published As

Publication number Publication date
TR200103858T2 (tr) 2002-06-21
SK18792001A3 (sk) 2002-07-02
CN1171888C (zh) 2004-10-20
NZ516095A (en) 2004-08-27
TWI229080B (en) 2005-03-11
EA200200121A1 (ru) 2002-06-27
DE60009296T2 (de) 2005-05-25
AR034242A1 (es) 2004-02-18
WO2001002399A1 (en) 2001-01-11
MY122631A (en) 2006-04-29
EP1065208A1 (en) 2001-01-03
CZ20014553A3 (cs) 2002-06-12
EA005372B1 (ru) 2005-02-24
DE60009296D1 (de) 2004-04-29
EP1196416A1 (en) 2002-04-17
IL147245A0 (en) 2002-08-14
CN1371376A (zh) 2002-09-25
YU89701A (sh) 2004-09-03
NO20016403D0 (no) 2001-12-28
ZA200200017B (en) 2003-01-02
HUP0300183A3 (en) 2005-12-28
CA2376673A1 (en) 2001-01-11
UA72923C2 (uk) 2005-05-16
AU5534900A (en) 2001-01-22
EE200100713A (et) 2003-04-15
PL352281A1 (en) 2003-08-11
AU774382B2 (en) 2004-06-24
EP1196416B1 (en) 2004-03-24
BG106229A (bg) 2002-08-30
KR20020015997A (ko) 2002-03-02
NO20016403L (no) 2002-03-01
US6747016B1 (en) 2004-06-08
JP2003503497A (ja) 2003-01-28
BR0012050A (pt) 2002-12-31
MXPA01013241A (es) 2002-06-21
ES2219353T3 (es) 2004-12-01
ATE262528T1 (de) 2004-04-15

Similar Documents

Publication Publication Date Title
HUP0203483A2 (hu) Purinszármazékok
HUP0203485A2 (hu) Purinszármazékok
RS101304A (sr) Indolni, azaindolni i srodni heterociklični 4-alkenil piperidinski amidi
HUP0203766A2 (hu) 5-Piridil-1,3-azol vegyületek, ezek előállítási eljárása és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
NO20044731L (no) Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere
MY144659A (en) 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
HK1089444A1 (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
HUP0200849A2 (hu) N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
HUP0500610A2 (hu) Indazol-, benzotiazol- és benzoizotiazol-származékok, ezeket tartalmazó gyógyszerkészítmények és ezek alkalmazása
SE9904738D0 (sv) Novel compounds
SE0002102D0 (sv) Chemical compound
ATE327977T1 (de) Tetrahydrochinolin-derivate als crth2 antagonisten
HUP9701265A2 (hu) Imidazolinszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítények
HUP0401333A2 (hu) Spiropirazol vegyületek és ezeket tartalmazó gyógyszerkészítmények
MY143958A (en) Quinazolinone derivatives and their use as cb agonists
HUP0203385A2 (en) Pyrimidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0002311A2 (hu) Ergolinszármazékok és szomatosztatin receptorként való alkalmazásuk
WO2003082861A3 (en) Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
HUP0300183A2 (hu) Sejt adhézió inhibítorként ható szubsztituált purinszármazékok
TW200628153A (en) Novel compounds
HUP0204154A2 (hu) Új benzotiadiazin vegyületek, eljárás előállításukra és ezen vegyületeket tartalmazó gyógyszerkészítmények
HUP0003624A2 (hu) 1,2,3,4-Tetrahidro-benzofuro[3,2-c]piridin-származékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
GB0308201D0 (en) Novel compounds
DK1525188T3 (da) Hidtil ukendte derivater af 4,4-dithiobis-(3-aminobutan-1-sulfonater) og sammensætninger, der indeholder dem

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished